Welcome to Francis Academic Press

Frontiers in Educational Research, 2020, 3(8); doi: 10.25236/FER.2020.030805.

Clinic Effect Study of Bao er Ning Decoction in the Remission Period of Children's Recurrent Respiratory Tract Infection

Author(s)

Xie Yingying

Corresponding Author:
Xie Yingying
Affiliation(s)

Wuhan Yaxin General Hospital 430056, China

Abstract

Objective: To study and analyze the clinical effect of Bao Er Ning Decoction in the remission period of children's recurrent respiratory tract infection. Methods: 100 children with recurrent respiratory tract infection in remission periodwere randomly selected from Dec 2018 to Dec .2019, which were divided into twogroups: regular group and research group,50 cases in each group. The regular groupwas treated with levamizopine orally, and the research group was treated with Baoerning Decoction. To analyze and compare the overall clinical efficacy, number of infections, and adverse reactions of each group. Results: the overall efficacy of the research group was higher than that of the regular group (P<0.05); the number of infections in the research group was significantly lower than regular group (P<0.05); there was no difference in adverse reactions of the two groups(P > 0.05). Conclusion: Bao Er Ning decoction is more effective for children with recurrent respiratory tract infection in remission period. the number of children with recurrent respiratory tract infection after treatment is significantly reduced, and the safety of Baoerning decoction is high, which is worthy of clinical promotion.

Keywords

​Bao Er Ning Decoction; children; repeated respiratory tract infection; clinical effect

Cite This Paper

Xie Yingying. Clinic Effect Study of Bao er Ning Decoction in the Remission Period of Children's Recurrent Respiratory Tract Infection. Frontiers in Educational Research (2020) Vol. 3 Issue 8: 19-22. https://doi.org/10.25236/FER.2020.030805.

References

[1] Du Jinghua, Yuan Bin (2019). Professor Yuan Bin discusses the treatment of recurrent respiratory tract infections in children from the “combination of evidence and quality”[J]. Journal of Liaoning University of Traditional Chinese Medicine, vol.21, no.1, pp.194-196.
[2] Wang Ningning (2017). To explore the clinical efficacy of traditional Chinese medicine treatment for children with repeated respiratory infections [J]. Chinese Medical Guide, vol.15, no.23, pp. 208-209.
[3] The Respiratory Group of the Pediatrics Branch of the Chinese Medical Association (2008). The Editorial Board of the Chinese Journal of Pediatrics. Clinical concepts and principles of management of repeated respiratory tract infections (revision) [J]. Chinese Journal of Pediatrics, vol.46, no.2, pp.108-110.
[4] Wang Lining, Wang Shouchuan, Han Xinmin, et al (2008). Guidelines for diagnosis and treatment of traditional Chinese medicine for children with repeated respiratory infections [J]. Pediatrics of Traditional Chinese Medicine, no.6, pp. 3-4.
[5] Li Guirong, Luan Weihong, Zhang Fangjun, et al (2017). Clinical study of Baoerning combined with montelukast in the treatment of children with allergic rhinitis [J]. Journal of Liaoning University of Traditional Chinese Medicine, vol.19, no.10, pp.125-128.
[6] Zhu Lian (2016). Clinical study of budesonide combined with Baoerning in the treatment of children with allergic rhinitis and asthma [J]. China Women and Children Health Research, vol.27, no.S1, pp. 25.
[7] Xue Bin (2016). Clinical effect of Baoerning granule combined with western medicine on children with recurrent respiratory tract infection [J]. Chinese Journal of Pharmacoeconomics, vol.11, no.2, pp.76-77.